Tris Pharma expands leadership team
This article was originally published in Scrip
Tris Pharma, a specialty company that develops innovative drug delivery technologies, has appointed Dominick DiPaolo vice-president of quality and Adam Drapczuk controller and director of finance. Mr DiPaolo most recently served at G&W Laboratories leading quality operations, and Mr Drapczuk, a certified public accountant, was most recently controller and director of finance at WestWard Pharmaceutical Corporation.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.